Lipid peroxidation in brain during aging in the senescence-accelerated mouse (SAM)

Neurobiology of Aging

Volumn 28, Issue 8, 2007, Pages 1170-1178

  Petursdottir, A L ^a   Farr, S A ^b,c   Morley, J E ^b,c   Banks, W A ^b,c   Skuladottir, G V ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Tocopherol; Aging; Amygdala; Brain; Hippocampus; Phospholipids; Polyunsaturated fatty acids; Senescence acceleration

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LIPID; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; POLYUNSATURATED FATTY ACID;

AGING; AMNESIA; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MATURATION; BRAIN REGION; CONTROLLED STUDY; FATTY ACID ANALYSIS; GROUPS BY AGE; HIPPOCAMPUS; LEARNING DISORDER; LIFESPAN; LIPID PEROXIDATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SENESCENCE ACCELERATED MOUSE;

AGE FACTORS; AGING; ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN CHEMISTRY; FATTY ACIDS; LIPID METABOLISM; LIPID PEROXIDATION; MALE; MICE; MICE, NEUROLOGIC MUTANTS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;

EID: 34249330230     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.05.033     Document Type: Article

References (55)

1. Arivazhagan P., and Panneerselvan C. Effect of dl-α-lipoic acid on neural antioxidants in aged rats. Pharmacol Res 42 (2000) 219-222
2. Balu M., Sangeetha P., Haripiya D., and Panneerselvam C. Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract. Neurosci Lett 383 (2005) 295-300
3. Bourre J.M., Dumont O., and Durand G. Brain phospholipids as dietary source of (n-3) polyunsaturated fatty acids for nervous tissue in the rat. J Neurochem 60 (1993) 2018-2028
4. Butterfield D.A., Drake J., Pocernich C., and Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 7 (2001) 548-554
5. Butterfield D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36 (2002) 1307-1313
6. Carrié I., Clément M., de Javel D., Francés H., and Bourre J.-M. Specific phospholipid fatty acid composition of brain regions in mice: effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation. J Lipid Res 41 (2000) 465-472
7. Carrié I., Clément M., de Javel D., Francés H., and Bourre J.-M. Phospholipid supplementation reverses behavioural and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J Lipid Res 41 (2000) 473-480
8. Craft N.E., Haitema T.B., Garnett K.M., Fitch K.A., and Dorey C.K. Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 8 (2004) 156-162
9. Delion S., Chalon S., Guilloteau D., Lejeune B., Besnard J.-C., and Durand G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or a n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res 38 (1997) 680-689
10. Drake J., Link C.D., and Butterfield D.A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging 24 (2003) 415-420
11. Farr S.A., Poon H.F., Dogrukol-Ak D., Drake J., Banks W.A., Eyerman E., et al. The antioxidants α-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 84 (2003) 1173-1183
12. Favreliére S., Stadelmann-Ingrand S., Huguet F., de Javel D., Piriou A., Tallineu C., et al. Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol Aging 21 (2000) 653-660
13. Flood J.F., and Morley J.E. Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J Gerontol 47 (1992) B52-B59
14. Flood J.F., Morley J.E., and Roberts E. An amyloid β-protein fragment, Aβ[12-28], equipotently impairs post-training memory processing when injected into different limbic system structures. Brain Res 663 (1994) 271-276
15. Folch J., Lees M., and Sloane Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 495-509
16. Gsell W., Conrad R., Hickethier M., Sofic E., Frölich L., Wichart I., et al. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem 64 (1995) 1216-1223
17. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 59 (1992) 1609-1623
18. Halliwell B. Oxygen radicals as key mediators in neurological disease: fact or fiction?. Ann Neurol 32 Suppl (1992) S10-S15
19. Hutton M., Perez-Tur J., and Hardy J. Genetics of Alzheimer's disease. Essays Biochem 33 (1998) 117-131
20. Ikezu T., Luo X., Weber G.A., Zhao J., McCabe L., Buescher J.L., et al. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. J Neurochem 85 (2003) 925-934
21. Jurgens G., Fell A., Ledinski G., Chen Q., and Paltauf F. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline and ethanolamine plasmalogens. Chem Phys Lipids 77 (1995) 25-31
22. Kalmijn S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging 4 (2000) 202-207
23. Kanski J., Aksenova M., Schöneich C., and Butterfield D.A. Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide (1-42). Free Radic Biol Med 32 (2002) 1205-1211
24. Karelson E., Bogdanovic N., Garlind A., Winblad B., Zilmer K., Kullisaar T., et al. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defence. Neurochem Res 26 (2001) 353-361
25. Kato K., Kurobe N., Suzuki F., Morishita R., Asano T., Sato T., et al. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease. J Mol Neurosci 3 (1991) 95-99
26. Kish S.J., Morito C.L., and Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochem Pathol 4 (1986) 23-28
27. Kolosova N.G., Shcheglova T.V., Sergeeva S.V., and Loskutova L.V. Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. Neurobiol Aging 27 (2006) 1289-1297
28. Kumar V.B., Farr S.A., Flood J.F., Kamlesh V., Franco M., Banks W.A., et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 21 (2000) 1769-1775
29. Lovell M.A., Ehmann W.D., Butler S.M., and Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurol 45 (1995) 1594-1601
30. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
31. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150 (1998) 40-44
32. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation is increased in the brain in Alzheimer's disease. Neurobiol Aging 19 (1998) 33-36
33. Markesbery W.R., Kryscio R.J., Lovell M.A., and Morrow J.D. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 58 (2005) 730-735
34. 2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal 7 (2005) 269-275
35. Morley J.E., Farr S.A., Kumar V.B., and Banks W.A. Alzheimer's disease through the eye of a mouse, acceptance lecture for the 2001 Gayle A Olson and Richard D Olson Prize. Peptides 23 (2002) 589-599
36. Morley J.E., Farr S.A., and Flood J.E. Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Membr 78 (2002) 125-138
37. 4-Isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochem 72 (1999) 734-740
38. Olney J.W. New insights and new issues in developmental neurotoxicology. Neurotoxicol 23 (2002) 659-668
39. Poon H.F., Joshi G., Sultana R., Farr S.A., Banks W.A., Morley J.E., et al. Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 1018 (2004) 86-96
40. Poon H.F., Farr S.A., Thongboonkerd V., Lynn B.C., Banks W.A., Morley J.E., et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Intern 46 (2005) 159-168
41. Porter N.A., Caldwell S.E., and Mills K.A. Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30 (1995) 277-290
42. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., and Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23 (1998) 81-88
43. Richardson J.S. Free radicals in the genesis of Alzheimer's disease. Ann NY Acad Sci 695 (1993) 73-76
44. Schuessel K., Leutner S., Cairns N.J., Muller W.E., and Eckert A. Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transmembr 111 (2004) 1167-1182
45. Soderberg M., Edlund C., Kristensson K., and Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26 (1991) 421-425
46. Su Q., Rowley K.G., and ÓDea K. Stability of individual carotenoids, retinol and tocopherols in human plasma during exposure to light and after extraction. J Chromatogr B 729 (1999) 191-198
47. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., et al. A new murine model of accelerated senescence. Mech Aging Dev 17 (1981) 183-194
48. Ulmann L., Mimouni V., Roux S., Porsolt R., and Posson J.-P. Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats. Prostagl Leukotr Essent Fatty Acids 64 (2001) 189-195
49. Varadarajan S., Yatin S., Aksenova M., and Butterfield D.A. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130 (2000) 184-208
50. Williams T.I., Lynn B.C., Markesbery W.R., and Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 27 (2006) 1094-1099
51. Yagi H., Katoh S., Akiguchi I., and Takeda T. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in resent memory. Brain Res 474 (1988) 86-93
52. Yasui F., Ishibashi M., Matsugo S., Kojo S., Oomura Y., and Sasaki K. Brain lipid hydroperoxide level increases in senescence-accelerated mice at an early age. Neurosci Lett 350 (2003) 66-68
53. Yatin S.M., Varadarajan S., Link C.D., and Butterfield D.A. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42). Neurobiol Aging 20 (1999) 325-330
54. Zhang Y., Appelkvist E.-L., Kristensson K., and Dallner G. The lipid compositions of different regions of rat brain during development and aging. Neurobiol Aging 17 (1996) 869-875
55. Zoeller R.A., Morand O.H., and Raetz C.R.H. A possible role for plasmalogens in protecting animal cells against photosensitized killing. J Biol Chem 263 (1988) 11590-11596